posted
BioPharmetics, Inc. Announces Final Approval From NASDAQ on Forward Stock Split and Name Change
NORTH HOLLYWOOD, CA -- (MARKET WIRE) -- 03/28/06 -- BioPharmetics, Inc. (OTC: BCSM) announced the company has received final approval from NASDAQ for the forward stock split and name change to be effective on the open of trading, Monday April 3, 2006.
The stock split will be accomplished through a stock dividend entitling each stockholder of record as of Friday, March 31, 2006, to receive two additional shares of common stock for every one share owned. The shares will be payable on Monday, April 3.
In addition to the stock split, the company has also received approval for their name change to be officially listed on the exchange as BioPharmetics, Inc.
"We're excited that the final approval process has been completed and the stock split and name change will be official on Monday April 3rd," stated Paul D. Lisenby, CEO of BioPharmetics, Inc. Mr. Lisenby adds, "This stock split will allow our company to offer our securities to a larger base of potential investors and will allow the company to move forward in seeking to be listed on the OTCBB as a fully reporting company in the very near future. We've also been informed there may be a symbol change and we will convey this to our shareholders upon notice from NASDAQ."
BioPharmetics, Inc. is a manufacturer and distributor of quality pharmaceutical, cosmetic, and anti-aging products. The company has three divisions: biotechnology, pharmaceuticals, and cosmetics/cosmeceuticals, working in unison to develop, manufacture, and distribute, high-quality products in the retail, wholesale, and professional markets. Brands currently offered include Toma(TM), Isseo(TM), Molo Africa(TM), Micha(TM), and Natural Angel(TM). BioPharmetics, Inc. also private labels many brands of cosmetics and Cosmeceuticals for salons and retail stores as well as compounding specialized prescriptions for doctors nationwide. The company currently sells products in over 23 countries worldwide.
This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Contact: Investor Relations Contact: Paul Deriso 925-465-6088
Company Contact: Paul D. Lisenby CEO BioPharmetics, Inc. 800-843-4606
redgurl19
posted NORTH HOLLYWOOD, CA -- (MARKET WIRE) -- 03/28/06 -- BioPharmetics, Inc. (OTC: BCSM) announced the company has received final approval from NASDAQ for the forward stock split and name change to be effective on the open of trading, Monday April 3, 2006.
The stock split will be accomplished through a stock dividend entitling each stockholder of record as of Friday, March 31, 2006, to receive two additional shares of common stock for every one share owned. The shares will be payable on Monday, April 3.
posted ![[Smile]](smile.gif)